🔗 Share this article

An underground economy for unapproved weight-loss drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on recent findings.

Experimental Drug Gaining Traction Online

Retatrutide, which remains in research studies, is being promoted by online personalities for its alleged weight-reducing properties. Followers are encouraged to contact these accounts privately for source information, while also obtaining discount codes.

Thriving Trade on Messaging Platforms

Additionally, a robust market exists on messaging services, where groups with numerous of participants share “before and after” photos, administration instructions and claims of rapid UK delivery. Sellers market the substance there before redirecting customers to WhatsApp for purchases.

Understanding The Experimental Drug

This medication is an investigational injection developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could help individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed online as the successor to Ozempic.

Healthcare Experts Voice Concerns

However, doctors and chemists have warned that the sale of what is still an unlicensed drug in the UK is a cause for concern and could result in individuals injecting substances of unknown origin.

Some experts stated the demand for the experimental drug could be linked to the increasing cost of licensed slimming products such as Mounjaro.

Legal Position and Enforcement

Marketing retatrutide on social media or messaging apps is prohibited in the UK, as it is an unlicensed medication that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.

Several influencers try to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and supply can still breach medicines, marketing, and customer regulations, potentially leading to fines, legal action or imprisonment.

Service Response and Content Elimination

Based on the social media company, the service has removed violative content and prohibited related hashtags and query recommendations. The organization stated it was dedicated to maintaining the platform safe and allocating resources in strengthening compliance measures.

Online Trading Operations

Investigations also discovered communities with up to 9,000 members marketing retatrutide using Telegram's built-in discovery tool, which functions like a online catalog. Entering “retatrutide” instantly brings up channels with thousands of users, populated with images of weight loss, positive reviews and step-by-step instructions for mixing or administering at residence.

Within minutes of joining one community, a seller posted contact information, where most transactions occur. The vendor sent an guidebook and guaranteed delivery within 48 hours. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one asked about weight, medical conditions or past usage.

Item Information and Costs

Within these groups, messages show dark colored packages with postal service labels, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at home with sterile water, or pre-filled injectors usually priced at 160 pounds for 20 milligrams. When asked how much time a pen should last, sellers give contradictory answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Safety Measures

A spokesperson for the messaging service stated it regularly monitored dangerous material on its platform including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are administering substances they can’t verify. Even if the science behind retatrutide is sound, these online versions may not contain what they advertise,” stated Jason Murphy, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to current price rises for authorized slimming drugs such as Mounjaro. “With prices increasing, patients are turning to online platforms. But counterfeit injections are highly dangerous. You can’t be certain what’s inside or whether the conditions they were produced in was clean,” she said.

Her staff has already seen individuals injured by self-injection from unverified sources. “We understand the frustration, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Producer Position

A representative from Eli Lilly stated the substance was in third stage clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they said, noting that any product “falsely representing itself as a Lilly investigational substance not yet authorized … may subject users to potentially significant medical dangers”.